Induction of T regulatory cells attenuates idiopathic nephrotic syndrome

Journal of the American Society of Nephrology

Volumn 20, Issue 1, 2009, Pages 57-67

  Le Berre, Ludmilla ^a   Bruneau, Sarah ^a   Naulet, Jeanne ^a   Renaudin, Karine ^b   Buzelin, Françoise ^b   Usal, Claire ^a   Smit, Helga ^a   Condamine, Thomas ^a   Soulillou, Jean Paul ^a   Dantal, Jacques ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LF 15 0195; LF 15 0296; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOXANTRONE; PYRROLIDINE DITHIOCARBAMATE; T CELL RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL TRANSFER; CONTROLLED STUDY; CYTOSKELETON; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RAT; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; REMISSION;

EID: 58149489323     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007111244     Document Type: Article

References (50)

1. Dantal J, Giral M, Hourmant M, Soulillou JP: Glomerulonephritis recurrences after kidney transplantation. Curr Opin Nephrol Hypertens 4: 146-154, 1995
2. Artero ML, Sharma R, Savin VJ, Vincenti F: Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23: 574-581, 1994
3. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP: Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330: 7-14, 1994
4. Dantal J, Godfrin Y, Koll R, Perretto S, Naulet J, Bouhours JF, Soulillou JP: Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 9: 1709-1715, 1998
5. Oliver JD 3rd, Simons JL, Troy JL, Provoost AP, Brenner BM, Deen WM: Proteinuria and impaired glomerular permselectivity in uninephrectomized fawn-hooded rats. Am J Physiol 267: F917-F25, 1994
6. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB: Adriamycin-induced nephrotic syndrome in rats: Sequence of pathologic events. Lab Invest 46: 16-23, 1982
7. Kuijpers MH, Provoost AP, de Jong W: Development of hypertension and proteinuria with age in fawn-hooded rats. Clin Exp Pharmacol Physiol 13: 201-209, 1986
8. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334: 878-883, 1996
9. Kato F, Watanabe M, Matsuyama M: Nephrotic syndrome in spontaneous thymoma rats, Buffalo/Mna. Biomed Res 4: 105-110, 1983
10. Nakamura T, Oite T, Shimizu F, Matsuyama M, Kazama T, Koda Y, Arakawa M: Sclerotic lesions in the glomeruli of Buffalo/Mna rats. Nephron 43: 50, 1986
11. Pollak MR: The genetic basis of FSGS and steroid-resistant nephrosis. Semin Nephrol 23: 141-146, 2003
12. Le Berre L, Godfrin Y, Gunther E, Buzelin F, Perretto S, Smit H, Kerjaschki D, Usal C, Cuturi C, Soulillou JP, Dantal J: Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest 109: 491-498, 2002
13. Le Berre L, Herve C, Buzelin F, Usal C, Soulillou JP, Dantal J: Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int 68: 2079-2090, 2005
14. Lebreton L, Jost E, Carboni B, Annat J, Vaultier M, Dutartre P, Renaut P: Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin: 2. Structural modifications of the spermidine moiety. J Med Chem 42: 4749-4763, 1999
15. Yang J, Bernier SM, Ichim TE, Li M, Xia X, Zhou D, Huang X, Strejan GH, White DJ, Zhong R, Min WP: LF15-0195 generates tolerogenic dendritic cells by suppression of NF-kappaB signaling through inhibition of IKK activity. J Leukoc Biol 74: 438-447, 2003
16. Zoja C, Benigni A, Remuzzi G: Cellular responses to protein overload: Key event in renal disease progression. Curr Opin Nephrol Hypertens 13: 31-37, 2004
17. Mudge SJ, Paizis K, Auwardt RB, Thomas RJ, Power DA: Activation of nuclear factor-kappa B by podocytes in the autologous phase of passive Heymann nephritis. Kidney Int 59: 923-931, 2001
18. Kerr PG, Atkins RC: The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro. Transplantation 48: 1048-1052, 1989
19. Chiffoleau E, Beriou G, Dutartre P, Usal C, Soulillou JP, Cuturi MC: Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J Immunol 168: 5058-5069, 2002
20. Tullius S, Heemann U, Hancock W, Azuma H, Tilney N: Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 220: 425-432, 1994
21. Dickneite G, Schorlemmer HU, Sedlacek HH: Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (+/-)-15-deoxyspergualin. Int J Immunopharmacol 9: 559-565, 1987
22. Waaga AM, Krzymanski M, Ulrichs K, Treumer J, Oko A, Muller-Ruchholtz W: In vitro analysis of the mode of action of the immunosuppressive drug 15-deoxyspergualin. Arch Immunol Ther Exp (Warsz) 44: 155-163, 1996
23. Nadler SG, Tepper MA, Schacter B, Mazzucco CE: Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science 258: 484-486, 1992
24. Hoeger PH, Tepper MA, Faith A, Higgins JA, Lamb JR, Geha RS: Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes. J Immunol 153: 3908, 1994
25. Tepper MA, Nadler SG, Esselstyn JM, Sterbenz KG: Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation. J Immunol 155: 2427-2436, 1995
26. Amemiya H: 15-Deoxyspergualin: A newly developed immunosuppressive agent and its mechanism of action and clinical effect - A review. Japan Collaborative Transplant Study Group for NKT-01. Artif Organs 20: 832-835, 1996
27. Amemiya H, Suzuki S, Ota K, Takahashi K, Sonoda T, Ishibashi M, Omoto R, Koyama F, Orita K, Takagi H, et al.: Multicentre clinical trial of antirejection pulse therapy with deoxyspergualin in kidney transplant patients. Int J Clin Pharmacol Res 11: 175-182, 1991
28. Min WP, Zhou D, Ichim TE, Strejan GH, Xia X, Yang J, Huang X, Garcia B, White D, Dutartre P, Jevnikar AM, Zhong R: Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 170: 1304-1312, 2003
29. Tesch GH, Hill PA, Wei M, Nikolic-Paterson DJ, Dutartre P, Atkins RC: LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease. Kidney Int 60: 1354-1365, 2001
30. Heslan JM, Beriou G, Le Luduec JB, Guillonneau C, Anegon I, Soulillou JP, Cuturi MC, Chiffoleau E: Accumulation of T cells with potent regulatory properties and restricted Vbeta7-TCR rearrangements in tolerated allografts. Transplantation 80: 1476-1484, 2005
31. Komesli S, Dumas C, Dutartre P: Analysis of in vivo immunosuppressive and in vitro interaction with constitutive heat shock protein 70 activity of LF08-0299 (Tresperimus) and analogues. Int J Immunopharmacol 21: 349-358, 1999
32. Thomas JM, Contreras JL, Jiang XL, Eckhoff DE, Wang PX, Hubbard WJ, Lobashevsky AL, Wang W, Asiedu C, Stavrou S, Cook WJ, Robbin ML, Thomas FT, Neville DM Jr: Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 68: 1660-1673, 1999
33. Ducoroy P, Micheau O, Perruche S, Dubrez-Daloz L, de Fornel D, Dutartre P, Saas P, Solary E: LF 15-0195 immunosuppressive agent enhances activation-induced T-cell death by facilitating caspase-8 and caspase-10 activation at the DISC level. Blood 101: 194-201, 2003
34. Schachter AD, Strehlau J, Zurakowski D, Vasconcellos L, Kim YS, Zheng XX, Gunshin Y, Overstreet SL, Benfield MR, Tejani A, Harmon WE, Herrin JT, Strom TB: Increased nuclear factor-kappaB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis. Transplantation 70: 1107-1110, 2000
35. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, Marshall B, Chandler P, Antonia SJ, Burgess R, Slingluff CL Jr, Mellor AL: Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870, 2002
36. Stephens GL, McHugh RS, Whitters MJ, Young DA, Luxenberg D, Carreno BM, Collins M, Shevach EM: Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 173: 5008-5020, 2004
37. Paust S, Lu L, McCarty N, Cantor H: Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 101: 10398-13403, 2004
38. Read S, Malmstrom V, Powrie F: Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192: 295-302, 2000
39. Aiello S, Cassis P, Cassis L, Tomasoni S, Benigni A, Pezzotta A, Cavinato RA, Cugini D, Azzollini N, Mister M, Longaretti L, Thomson AW, Remuzzi G, Noris M: DnIKK2-transfected dendritic cells induce a novel population of inducible nitric oxide synthase-expressing CD4+CD25- cells with tolerogenic properties. Transplantation 83: 474-484, 2007
40. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A: Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 3: 33-41, 2002
41. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, Candeloro P, Belladonna ML, Bianchi R, Fioretti MC, Puccetti P: CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3: 1097-1101, 2002
42. Sellier-Leclerc AL, Duval A, Riveron S, Macher MA, Deschenes G, Loirat C, Verpont MC, Peuchmaur M, Ronco P, Monteiro RC, Haddad E: A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol 18: 2732-2739, 2007
43. Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H, Mayer G, Gunsilius E, Rosenkranz AR: CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 16: 1360-1370, 2005
44. Engelbrecht G, Kahn D, Duminy F, Hickman R: New rapid technique for renal transplantation in the rat. Microsurgery 13: 340-344, 1992
45. Livak K, Schmittgen T: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001
46. McWhinnie D, Thompson J, Taylor H, Chapman J, Bolton E, Carter N, Wood R, Morris P: Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation 42: 352-358, 1986
47. Godfrin Y, Dantal J, Bouhours JF, Heslan JM, Soulillou JP: A new method of measuring albumin permeability in isolated glomeruli. Kidney Int 50: 1352-1357, 1996
48. Bouchot O, Anegon I, Romaniuk A, Jacques Y, Paineau J, Soulillou JP: Interleukin 2 receptor in rat heart allograft rejection. Transplantation 48(6): 918-922, 1989
49. Tsuchida M, Hirahara H, Matsumoto Y, Abo T, Eguchi S: Induction of specific unresponsiveness to cardiac allografts by short-term administration of anti-T cell receptor alpha beta antibody. Transplantation 57(2): 256-262, 1994
50. Fidler JM, DeJoy SQ, Gibbons JJ: Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function. J Immunol 137(2): 727-732, 1986